Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study
2017 · The Lancet Oncology · 504 citations
https://doi.org/10.1016/s1470-2045(17)30243-7
J
Janet C. Lindsey
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
100
Papers
7.4K
Citations
34
h-index
48
i10-index
Janet C. Lindsey is an academic researcher from University of Kindu. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Epigenetics and DNA Methylation & Hedgehog Signaling Pathway Studies. The author has an h-index of 34, co-authored 85 publications.
ORCID: 0000-0002-5043-7513Papers by this author
worksSubgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in Medulloblastoma
2013 · Journal of Clinical Oncology · 474 citations
https://doi.org/10.1200/jco.2012.48.5052
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
2019 · Acta Neuropathologica · 292 citations
https://doi.org/10.1007/s00401-019-02020-0
Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity
2020 · Nature Communications · 227 citations
https://doi.org/10.1038/s41467-020-18070-y
Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease
2014 · Cancer Cell · 205 citations
https://doi.org/10.1016/j.ccell.2014.11.002
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies
2013 · Acta Neuropathologica · 172 citations
https://doi.org/10.1007/s00401-012-1077-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat